2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Avant Immunotherapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Peru-15 Vaccine When Given With Measles Vaccine in Healthy Indian and Bangladeshi Infants Peru-15 Vaccine, Placebo - Cholera, Diarrhea | Phase 2 | Terminated | International Vaccine Institute | 74 | 2008-11-01 | 2012-08-01 |
| Dose Ranging Study to Determine the Safety, Reactogenicity and Immunogenicity of Typhoid Fever Vaccine (Ty800) in Healthy Adult Subjects Ty800 (Salmonella typhi) Oral Vaccine - Typhoid Fever | Phase 2 | Completed | Avant Immunotherapeutics | 180 | 2007-07-01 | 2008-07-02 |
| Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery TP10 - Myocardial Ischemia, Coronary Arteriosclerosis | Phase 2 | Completed | Avant Immunotherapeutics | 300 | 2004-04-01 | 2007-07-20 |
Aortic Valve Insufficiency (1) · Cholera (1) · Coronary Artery Disease (1) · Diarrhea (1) · Mitral Valve Insufficiency (1) · Myocardial Ischemia (1) · Typhoid Fever (1) · Vibrio Infections (1)
United States (2) · Bangladesh (1) · India (1)
Clark McKeever, MD (1) · John Clemens, MD (1)